Effect of inhibitors of macromolecular synthesis on HL-A antibody mediated lysis of cultured lymphoblasts.
D000756:Anemia, Sideroblastic / Q000276:immunology; D000818:Animals; D002051:Burkitt Lymphoma / Q000276:immunology; D002250:Carbon Radioisotopes; D002460:Cell Line; D002462:Cell Membrane / Q000187:drug effects / Q000276:immunology; D002478:Cells, Cultured; D003165:Complement System Proteins; D003513:Cycloheximide / Q000494:pharmacology; D003601:Cytotoxicity Tests, Immunologic; D003609:Dactinomycin / Q000494:pharmacology; D003864:Depression, Chemical; D006649:Histocompatibility Antigens; D006801:Humans; D007106:Immune Sera; D007518:Isoantibodies; D007930:Leucine / Q000378:metabolism; D007951:Leukemia, Myeloid / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology*; D046911:Macromolecular Substances; D011691:Puromycin / Q000494:pharmacology; D011817:Rabbits / Q000276:immunology; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D002250:Carbon Radioisotopes; D006649:Histocompatibility Antigens; D007106:Immune Sera; D007518:Isoantibodies; D046911:Macromolecular Substances; D014316:Tritium; D003609:Dactinomycin; D011691:Puromycin; D003165:Complement System Proteins; D003513:Cycloheximide; D007930:Leucine; D013936:Thymidine